Events

We are proud to announce our company's participation in Alzheimer's Association International Conference (AAIC) 2023 organized by the Alzheimer's Association.We would like to thank to everyone for taking their time to visit our booth (#111), at AAIC23.Our booth presented our innovative Biomarker Analyzers, Biomarker Analysis and Ultra-High Sensitivity Detection. Our in-depth conversations and exchange of real-world experiences are a testament to the potential that lies in our FOPPR's One-Stop Solution. We are very excited to see how our innovative tools can continue to drive your research forward.Information on Alzheimer's Association International Conference:AAIC is the largest and most influential meeting dedicated to advancing dementia science. AAIC is a five-day event that is defined by a diverse scientific program, which is shaped by your work and for your work.Each year, AAIC convenes researchers, clinicians, and dementia professionals from all career stages to share breaking research discoveries that will lead to methods of prevention and treatment and improvements in diagnosis for Alzheimer's disease. From basic science to dementia care, every aspect of the the related growing knowledge of dementia is incorporated into this world-class conference.

Come hear our CEO, Tony Chung, share our company's success story at the two-day forum hosted by the National Biotechnology Research Park (NBRP) on May 4th and 5th. During the event, Tony will speak about collaborations with Foreign, Commonwealth and Development Office, Netherlands Office Taipei (荷蘭在台辦事處) & TigerAccelerator. Two collaborators that have allowed our company to link the UK and Dutch ecosystems and achieve a successful soft landing in Cambridge, UK and Utrecht, the Netherlands.Information on NBRP Demo Day:The National Biotechnology Research Park Investment Promotion and Talent and Technology Matchmaking Conference promotes a deeper BIO-ICT cross-domain cooperation and start the link of international biomedical parks.Want to get a better grasp the pulse of global trends, understand the pain points of cross-domain integration, explore cutting-edge technologies, attract outstanding talents, and connect international business opportunities? Then come to NBRP Demo Day!! Learn about elements required for biomedical innovation at one time, leading you to become a leader in international biomedical development, and quickly connect to business opportunities now!

Tony Chung, CEO of Instant NanoBiosensors (INB), was invited by the National Biotechnology Research Park (NBRP) to give a talk on: “How FOPPR technology can assist customers in developing ultra-sensitive assays through affinity and epitope binning analysis.”INB's FOPPR technology for affinity and epitope binning analysis can improve the accuracy, reproducibility, and efficiency of ultra-sensitive assays. A tool that is becoming increasingly important in the field of diagnostics, drug discovery, and biomanufacturing.Information on NBRP:NBRP is committed to creating an innovative biomedical ecosystem, connecting high-quality basic research forward, capturing the commercial field backward, implementing chemical research for use, and integrating industry, government, academia and research to promote the development of Taiwan's biotechnology innovation. The resources of the department assist the product development and preclinical trials of biotechnology innovations and provide necessary assistance in a timely manner to cross the valley of death.

Come join our joint webinar with Abcam!! The main topic that will be covered is “Enhancing ultrasensitive affinity analysis with highly specific recombinant antibodies.”In this webinar, you will learn to grasp the key points for the advancement of research, drug discovery and product development easily. You will also get an exclusive chance to hear about how Abcam enables Instant NanoBiosensors (INB) to develop the right content to meet users' demanding needs. Subjects such as antibody affinity and specificity using INB's proprietary light-sensing platform and formulate the best strategy.Presenters:Ryan Chong, Ph.D., Sales Director, Biotech & Pharma APAC, AbcamTony Chung, Chief Executive Officer, Instant NanoBiosensorsOur speaking time, on November 2nd is at 11:00 am (IST) or 05:00 pm (AEDT). Don't hesitate, sign up for free now!! HERE

We are excited to announce our jointly workshop organized by Abcam and Instant NanoBiosensors!! We will hold 3 workshops in partnership with Abcam. Join us in learning about FOPPR technology and how listed companies such as, Abcam, and independent labs can benefit greatly from Affinity Analysis and Epitope Binning in antibody selection.​​​​​​​The high sensitivity of the fiber optic particle plasmon resonance sensing technology (FOPPR™) can help researchers to accurately conduct molecular detection, to see the whole picture of proteins and biomarkers in cells, shorten the time of follow-up experiments and accelerate the development process.Abcam:The leading supplier of protein research tools to life scientistsInstant NanoBiosensors: Ultra-sensitive biomarker platform from analysis to diagnosisMore information can be found HERE.